Clinical Trials on Agoraphobia With Panic Attacks in South Africa
Total 1 results
-
VA Office of Research and DevelopmentRecruitingMajor Depressive Disorder | Posttraumatic Stress Disorder | Panic Disorder and AgoraphobiaUnited States
Sponsors and Collaborators
- Paulo Sérgio Gomes Nogueira Borges
- Iyad Naeem Muhammad, PhD
- Eurotrials Brasil Consultores Cientificos Ltda
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Sudimplant SAS - Groupe TBR
- Korea Otsuka International Asia Arab
- S-Biotek Holding ApS
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- Rivierduinen, Centre for Personality disorders Jelgersma
- Gunkang Pharmaceuticals, Inc
- United States Department of Defense (DOD)
- Arsha Vidya Tirtha
- Julian Taylor Green
- Foshan Sanshui District People's Hospital
- Oblikue Consulting
- University of Applied Sciences Jena
- Plethora Solutions Ltd
- Lilly PharmaceuticalCompany
- View Full List
Medical Conditions
- Gray Platelet Syndrome
- Malaria,Falciparum
- Blepharospasm of Both Eyelids
- Testicular Teratoma
- Vibration; Exposure
- Deformity Flexion
- Immunologically-induced Lung Disease
- Chemotherapy-Induced Neutropenia
- Visual Attention Span Deficit
- Puberty, Delayed
- Advance Directive Completion
- Anemia Acute
- Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
- Serum Albumin Low
- Huntington Chorea
- Thyroid and Parathyroid Surgery
- Post-discharge Pharmacist Counseling to Prevent Readmissions
- Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
- Hypothermia Following Anesthesia, Sequela
- Brain Tumor, Primary
- View Full List
Drug Interventions
- Oxycodone
- MMV390048 120mg
- Celecoxib
- S-Adenosyl-Methionine
- Cytisine
- F520
- Pegfilgrastim
- Ebselen
- Rovalpituzumab tesirine
- Cyanoacrylate
- Bimatoprost 0.03% eye drops
- Pemetrexed
- Standard medical therapy
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Mineralocorticoid receptor antagonist
- Vosaroxin
- ABY-035 i.v.
- Furmonertinib 160 mg
- Acalabrutinib in combination with VR
- Sorafenib
- View Full List
CROs by country
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Thailand
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in Uruguay
- CRO list by country